ClinicalTrials.gg
CompletedNCT07759726CALMAS-CSUpdated Aug 12, 2026

Cellphone Access for Lowered Maternal Anxiety and Stress in Cesarean Sections

An interventional study of Cell Phone Use in Anxiety and Stress (Psychology), sponsored by Beirut Arab University. Completed at 1 site in Lebanon. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-12.

Primary conditionAnxiety Disorders(the registry's first term)UnverifiedIs this wrong?The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Beirut Arab University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
82
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

This study looks at whether allowing mothers to use their personal cellphone during a planned cesarean section (C-section) under spinal anesthesia can reduce stress and anxiety and improve their overall birth experience. During a cesarean section under spinal anesthesia, the mother is awake, which can sometimes cause feelings of anxiety or stress.

Women taking part in this study will be randomly assigned to one of two groups. One group will be allowed to use their cellphone freely during the surgery, while the other group will follow the usual hospital practice, which does not allow cellphone use in the operating room. All medical care, anesthesia, and surgical procedures will be exactly the same for both groups.

The study will measure mothers' anxiety levels before surgery, during the operation, and within 24 hours after delivery using simple questionnaires. Mothers will also be asked about their satisfaction with their birth experience. In addition, the study will assess stress levels of a close family member (such as a partner) shortly after the delivery.

Participation in this study is voluntary and involves minimal risk. Allowing or not allowing cellphone use does not affect medical care in any way, and participants may withdraw at any time without any impact on their treatment. The results of this study may help hospitals improve patient-centered care and make cesarean deliveries a calmer and more positive experience for mothers and their families.

Read the detailed description

Cesarean section performed under regional (spinal) anesthesia allows the mother to remain awake throughout the procedure, which can be associated with heightened anxiety, stress, and feelings of loss of control. While medical and surgical outcomes of cesarean delivery have been extensively studied, less attention has been given to modifiable, non-pharmacologic factors that may improve the psychological experience of the mother during surgery.

Personal mobile phones are an integral part of daily life and serve as a means of emotional support, reassurance, and connection. Allowing mothers to use their cellphones during cesarean section-such as communicating with family members, or engaging in video calls-may help reduce intraoperative anxiety and enhance maternal satisfaction. Despite this, many operating rooms maintain strict policies prohibiting cellphone use, largely based on tradition rather than evidence regarding patient-centered outcomes.

The CALMAS-CS Trial is a prospective, randomized, parallel-group study designed to evaluate the psychological impact of unrestricted personal cellphone use during elective cesarean section under spinal anesthesia. Participants are randomly assigned to either an intervention group, in which personal cellphone use is permitted throughout the procedure, or a control group, which follows standard operating room policy prohibiting cellphone use. All participants receive identical surgical, anesthetic, and perioperative care; the only difference between groups is access to personal cellphone use during surgery.

Maternal anxiety is assessed at predefined perioperative timepoints using validated instruments, including the State-Trait Anxiety Inventory and a visual analogue scale for anxiety. Maternal satisfaction with the cesarean experience is evaluated postoperatively using a structured questionnaire. In addition, the study explores the psychological impact on next of kin by assessing their stress levels and perceived involvement when remote communication during surgery is permitted.

This trial focuses on a low-risk, non-pharmacologic intervention that does not interfere with standard medical care. By systematically evaluating the psychological effects of cellphone access during cesarean delivery, the study aims to generate evidence that may inform future institutional policies and contribute to more patient-centered obstetric care. The findings may have implications for improving maternal experience, family engagement, and overall satisfaction with planned cesarean delivery.

02

Conditions studied

  • Anxiety
  • Stress (Psychology)

Browse trials for

Keywords

  • Cesarean Section
  • Spinal Anesthesia
  • Anxiety
  • Satisfaction
  • Cellphone
  • Mobile Phone
  • Non-Pharmacological Intervention
03

In context

Anxiety Disorders Unverified

7,201 studies on the registry are indexed under Anxiety Disorders; 1,682 are open to participants now.

This study's enrollment of 82 is close to the median of 80 across 6,057 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Beirut Arab University is the lead sponsor of 16 studies on the registry; 6 are open to participants now.

Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Low-risk pregnant patients scheduled for Cesarean section under spinal anesthesia, who are literate and able to provide an .

Exclusion criteria

Exclusion Criteria:

  • Patients undergoing normal vaginal deliveries.
  • Patients who underwent emergency Cesarean sections.
  • Non-Lebanese patients.
  • High-risk pregnancies, as determined by medical assessment.
  • Patients diagnosed with pre-existing anxiety disorders.
  • Patients for whom spinal anesthesia was difficult to perform (requiring more than two attempts for successful administration).
  • Patients receiving sedation during the procedure.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
82 participants (actual)

Study arms

  • Experimental
    Cell Phone Use

    Participants assigned to this experimental arm will be allowed unrestricted use of their personal mobile phone during elective cesarean section performed under spinal anesthesia. Cellphone use is permitted throughout the intraoperative period and may include texting, voice or video calls, provided that use does not interfere with surgical sterility, patient monitoring, or clinical care. All anesthetic, surgical, and perioperative management will otherwise follow standard institutional protocols and will be identical to the control arm.

    Behavioral: Cell Phone Use

  • No intervention
    Standard Care (No Cellphone Use)

    Participants assigned to this control arm will undergo elective cesarean section under spinal anesthesia following standard operating room protocol, which does not allow access to personal mobile phones during the procedure. No communication with family members or next of kin will occur during the intraoperative period. All anesthetic, surgical, and perioperative care will be provided according to routine institutional practice and will be identical to that of the experimental arm, with the only difference being the absence of cellphone use.

Interventions

  • BehavioralCell Phone Use

    Participants assigned to this experimental arm will be allowed unrestricted use of their personal mobile phone during elective cesarean section performed under spinal anesthesia. Cellphone use is permitted throughout the intraoperative period and may include texting, voice or video calls, provided that use does not interfere with surgical sterility, patient monitoring, or clinical care. All anesthetic, surgical, and perioperative management will otherwise follow standard institutional protocols and will be identical to the control arm.

06

What researchers measure

Primary outcomes

  1. Maternal Anxiety Levels During Elective Cesarean Section

    Maternal anxiety will be assessed using the Visual Analogue Scale for Anxiety (VAS-A). Anxiety scores will be measured at predefined perioperative timepoints to evaluate the effect of unrestricted personal cellphone use during elective cesarean section under spinal anesthesia. Higher scores indicate greater anxiety. The primary comparison will assess differences in anxiety levels between the intervention and control groups.

    Time frame: Preoperative (upon admission to the operating room), intraoperative (before and after delivery of the baby, and before skin closure), and postoperative (within 24 hours after cesarean section)

Secondary outcomes

  1. Maternal Postoperative Satisfaction

    Maternal satisfaction with the cesarean section experience will be assessed using a structured self-administered questionnaire adapted from validated satisfaction instruments. The questionnaire evaluates overall satisfaction with the surgical experience, communication, emotional support, and perceived quality of care. Higher scores indicate greater satisfaction.

    Time frame: Within 24 hours after cesarean section

  2. Next of Kin Stress Levels

    Stress levels of the participant's next of kin will be assessed using a Visual Analogue Scale for Stress (VAS-S), a self-reported scale ranging from 0 (no stress) to 10 (extreme stress). This outcome evaluates whether intraoperative communication via cellphone use influences perceived stress among family members.

    Time frame: Within 2 hours after cesarean section

07

Study locations

1 site
  • Hammoud Hospital University Medical Center (HHUMC)
    Sidon, Lebanon
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared with other researchers outside the study team. This decision is based on institutional data protection policies, ethical considerations related to participant confidentiality, and the sensitive nature of psychological and perioperative data collected during childbirth. De-identified aggregate results will be reported through peer-reviewed publications and trial registry postings.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07759726
Lead sponsor
Beirut Arab University
Collaborators
Hammoud Hospital University Medical Center
Responsible party
Bahaa Bou Dargham (Anesthesia & Reanimation Consultant / Lecturer of Anesthesia, Beirut Arab University) — Principal investigator
First posted
Aug 12, 2026
Start date
Jan 1, 2026
Primary completion
Jun 1, 2026
Completion
Jun 1, 2026
Last update
Aug 12, 2026

Study contacts

Bahaa W Bou Dargham, md
principal investigator · Hammoud Hospital University Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion